1,721,167 research outputs found

    Mid-term safety profile evaluation of Bio-A absorbable synthetic mesh as cruroplasty reinforcement

    No full text
    Purpose: The aim of the present paper is to report the results of a single institution series of hiatal hernia repair (HHR) with augmented mesh hiatoplasty focusing on safety and efficacy profile of Bio-A absorbable synthetic mesh. Materials and methods: A retrospective evaluation of prospectively maintained database showed 120 consecutive patients submitted to HHR reinforced with bio-absorbable synthetic mesh. The study populations included two groups: (A) 92 obese patients—reinforced hiatoplasty concurrent with bariatric procedure; (B) 28 non-obese patients—reinforced hiatoplasty concurrent with antireflux surgery. Symptoms assessment was made with GERD-HRQL and Rome III. The X-ray with barium swallow, the CT scan, in selected cases, and the endoscopy were used as recurrence evaluation and as endoscopic complications assessment. Only patients with a mean follow-up of 12 months were included in this study. A Cox hazard was made to evaluate factors affecting the recurrence. Results: No case of intra-peri and post-operative (mean follow-up of 41 months) complications mesh related were registered. The dysphagia-rate was 8.7% for Group A and 11% for Group B. 74% of Group A and 61% of Group B patients are actually PPIs free with median GERD-HRQL score of 4 (from 16) and 6 (from 23), respectively (difference pre-post-operative < 0.05). Recurrence rate was 5.4% in Group A and 7.1% in Group B. The Cox hazard analysis showed that the use of more than four stitches for cruroplasty represents a negative factor on recurrence (HR = 8; p < 0.05). Conclusions: This is, in our knowledge, the largest report (120 consecutive patients) with mid-term follow-up (41 months of mean FU) on bio-absorbable mesh on the hiatus in obese and non-obese patients. These results supports the use of absorbable mesh for HHR (safe profile—0% of complications rate), showing excellent recurrence rate results and good GERD symptoms control

    Mini gastric bypass with 4k technology as treatment of morbid obesity in patient with ventriculoperitoneal shunt

    Full text link
    Ventriculoperitoneal (VP) shunt placement is used to treat idiopathic intracranial pressure. Obesity is a risk factor related to shunt migration, dislodgement, and subsequent failure due to increased intraabdominal pressure. Minigastric bypass consists in both restrictive and malabsorbative mechanisms, and indications to this procedure as an efficient primary and redo procedure are increasing lately. Technology can always improve the surgical act, and 4K vision is spreading in many operating rooms. Laparoscopic approach is subject to continuous change. Ultrahigh definition is the next development in video technology, it delivers fourfold more detail than full high definition resulting in improved fine detail, increased texture, and an almost photographic emulsion of smoothness of the image. New 4K ultrahigh-definition technology might remove the current need for the use of polarised glasses. We present the laparoscopic one anastomosis gastric bypass, done with the new 4K technology, as primary bariatric procedure for morbid obese patient with VP shunt

    Correction to: SICE national survey: current state on the adoption of laparoscopic approach to the treatment of colorectal disease in Italy (Updates in Surgery, (2019), 71, 1, (77-81), 10.1007/s13304-018-0606-5)

    No full text
    Page 80, Acknowledgements section: The surname and given name of author Riccardo Brachet Contul was incorrectly published. The correct surname and given name should read as: Surname: Brachet Contul and Given Name: Riccardo

    Alexithymia in obese patients seeking surgical Treatment: comparison between Toronto Structered Interview for Alexithtmia and 20-item Toronto Alexithymia Scale”

    No full text
    Recent studies highlight the need to investigate the presence of psychological factors in obese patients because they show an influence on the weight loss after bariatric surgery. Alexithymia could represent a psychological risk factor for the outcome of the surgical treatment, although actually the relation between alexithymia and obesity is uncertain. The literature on alexhithymia measurement claims the importance of a multimethod assessment. The first aim is to assess alexithymia in severly obese patients by using a multimethod measurement (self-report and interview). Further aim is to investigate the relationship between alexithymia and body weight. Forty-five severly obese patients (30 Female; mean age 42,6; mean body weight 122,13 Kg) underwent the 20-item Toronto Alexithymia Scale (TAS-20) and the Toronto Structured Interview for Alexithymia (TSIA), which represents the first clinically structured interview. Significant discordance was found between the two alexithymia measures: TSIA scores highlighted a greater level of alexithymia compared with self-report scores. Furthermore only TSIA total score was significantly related to Body Weight (p= .03; r= .34). We can hypothesize that the TSIA is a more sensitive instrument in evaluating alexithymia: minimizing obese patients’ negation tendency. A multimethod measurement seems useful to have clinically relevant information on our sample
    corecore